MLC1 (Middle Region) Peptide
Reactivity: Human
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN980115
Quick Overview for MLC1 (Middle Region) Peptide (ABIN980115)
Target
MLC1
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-MLC1 antibody (Catalog #: ARP35249_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MLC1
-
Background
-
MLC1 may be a transporter. It may act as a non-selective neuronal cation channel.The function of this gene product is unknown, however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified.
Alias Symbols: KIAA0027, LVM, MLC, VL
Protein Interaction Partner: DAPK2,TPT1,MYLK
Protein Size: 377 -
Molecular Weight
- 41 kDa
-
Gene ID
- 23209
-
NCBI Accession
- NM_015166, NP_055981
-
UniProt
- Q15049
Target
-
You are here:
